HSS Journal

, Volume 2, Issue 2, pp 102–113

The Central Role of Wear Debris in Periprosthetic Osteolysis

  • P. Edward Purdue
  • Panagiotis Koulouvaris
  • Bryan J. Nestor
  • Thomas P. Sculco
Original Paper

Abstract

Periprosthetic osteolysis remains the leading complication of total hip arthroplasty, often resulting in aseptic loosening of the implant, and a requirement for revision surgery. Wear-generated particular debris is the main cause of initiating this destructive process. The purpose of this article is to review recent advances in our understanding of how wear debris causes osteolysis, and emergent strategies for the avoidance and treatment of this disease. The most important cellular target for wear debris is the macrophage, which responds to particle challenge in two distinct ways, both of which contribute to increased bone resorption. First, it is well known that wear debris activates proinflammatory signaling, which leads to increased osteoclast recruitment and activation. More recently, it has been established that wear also inhibits the protective actions of antiosteoclastogenic cytokines such as interferon gamma, thus promoting differentiation of macrophages to bone-resorbing osteoclasts. Osteoblasts, fibroblasts, and possibly lymphocytes may also be involved in responses to wear. At a molecular level, wear particles activate MAP kinase cascades, NFκB and other transcription factors, and induce expression of suppressors of cytokine signaling. Strategies to reduce osteolysis by choosing bearing surface materials with reduced wear properties (such as metal-on-metal) should be balanced by awareness that reducing particle size may increase biological activity. Finally, although therapeutic agents against proinflammatory mediators [such as tumor necrosis factor (TNF)] and osteoclasts (bisphosphonates and molecules blocking RANKL signaling) have shown promise in animal models, no approved treatments are yet available to osteolysis patients. Considerable efforts are underway to develop such therapies, and to identify novel targets for therapeutic intervention.

Key words

aseptic loosening periprosthetic osteolysis wear debris 

References

  1. 1.
    Harris WH (2001) Wear and periprosthetic osteolysis: the problem. Clin Orthop Relat Res 66–70Google Scholar
  2. 2.
    Dumbleton JH, Manley MT, Edidin AA (2002) A literature review of the association between wear rate and osteolysis in total hip arthroplasty. J Arthroplasty 17:649–661PubMedGoogle Scholar
  3. 3.
    Schmalzried TP, Jasty M, Harris WH (1992) Periprosthetic bone loss in total hip arthroplasty. Polyethylene wear debris and the concept of the effective joint space. J Bone Jt Surg Am 74:849–863Google Scholar
  4. 4.
    Hirakawa K, Bauer TW, Stulberg BN et al. (1996) Comparison and quantitation of wear debris of failed total hip and total knee arthroplasty. J Biomed Mater Res 31:257–263PubMedGoogle Scholar
  5. 5.
    Margevicius KJ, Bauer TW, McMahon JT et al. (1994) Isolation and characterization of debris in membranes around total joint prostheses. J Bone Jt Surg Am 76:1664–1675Google Scholar
  6. 6.
    Schwarz EM, Benz EB, Lu AP et al. (2000) Quantitative small-animal surrogate to evaluate drug efficacy in preventing wear debris-induced osteolysis. J Orthop Res 18:849–855PubMedGoogle Scholar
  7. 7.
    Millett PJ, Allen MJ, Bostrom MP (2002) Effects of alendronate on particle-induced osteolysis in a rat model. J Bone Jt Surg Am 84-A:236–249Google Scholar
  8. 8.
    Merkel KD, Erdmann JM, McHugh KP et al. (1999) Tumor necrosis factor-alpha mediates orthopedic implant osteolysis. Am J Pathol 154:203–210PubMedGoogle Scholar
  9. 9.
    Shanbhag AS, Hasselman CT, Rubash HE (1997) The John Charnley Award. Inhibition of wear debris mediated osteolysis in a canine total hip arthroplasty model. Clin Orthop Relat Res:33–43Google Scholar
  10. 10.
    Wooley PH, Morren R, Andary J et al. (2002) Inflammatory responses to orthopaedic biomaterials in the murine air pouch. Biomaterials 23:517–526PubMedGoogle Scholar
  11. 11.
    Warme BA, Epstein NJ, Trindade MC et al. (2004) Proinflammatory mediator expression in a novel murine model of titanium-particle-induced intramedullary inflammation. J Biomed Mater Res B Appl Biomater 71:360–366PubMedGoogle Scholar
  12. 12.
    Yang SY, Wu B, Mayton L et al. (2004) Protective effects of IL-1Ra or vIL-10 gene transfer on a murine model of wear debris-induced osteolysis. Gene Ther 11:483–491PubMedGoogle Scholar
  13. 13.
    Blaine TA, Rosier RN, Puzas JE et al. (1996) Increased levels of tumor necrosis factor-alpha and interleukin-6 protein and messenger RNA in human peripheral blood monocytes due to titanium particles. J Bone Jt Surg Am 78:1181–1192Google Scholar
  14. 14.
    Nakashima Y, Sun DH, Trindade MC et al. (1999) Signaling pathways for tumor necrosis factor-alpha and interleukin-6 expression in human macrophages exposed to titanium–alloy particulate debris in vitro. J Bone Jt Surg Am 81:603–615Google Scholar
  15. 15.
    Wimhurst JA, Brooks RA, Rushton N (2001) Inflammatory responses of human primary macrophages to particulate bone cements in vitro. J Bone Jt Surg Br 83:278–282Google Scholar
  16. 16.
    Ingham E, Green TR, Stone MH et al. (2000) Production of TNF-alpha and bone resorbing activity by macrophages in response to different types of bone cement particles. Biomaterials 21:1005–1013PubMedGoogle Scholar
  17. 17.
    Maloney WJ, James RE, Smith RL (1996) Human macrophage response to retrieved titanium alloy particles in vitro. Clin Orthop Relat Res :268–278Google Scholar
  18. 18.
    Skripitz R, Aspenberg P (2000) Pressure-induced periprosthetic osteolysis: a rat model. J Orthop Res 18:481–484PubMedGoogle Scholar
  19. 19.
    Greenfield EM, Bi Y, Ragab AA et al. (2005) Does endotoxin contribute to aseptic loosening of orthopedic implants? J Biomed Mater Res B Appl Biomater 72:179–185PubMedGoogle Scholar
  20. 20.
    Saleh KJ, Thongtrangan I, Schwarz EM (2004) Osteolysis: medical and surgical approaches. Clin Orthop Relat Res:138–147Google Scholar
  21. 21.
    Yagil-Kelmer E, Kazmier P, Rahaman MN et al. (2004) Comparison of the response of primary human blood monocytes and the U937 human monocytic cell line to two different sizes of alumina ceramic particles. J Orthop Res 22:832–838PubMedGoogle Scholar
  22. 22.
    Xing S, Waddell JE, Boynton EL (2002) Changes in macrophage morphology and prolonged cell viability following exposure to polyethylene particulate in vitro. Microsc Res Tech 57:523–529PubMedGoogle Scholar
  23. 23.
    Chiba J, Rubash HE, Kim KJ et al (1994) The characterization of cytokines in the interface tissue obtained from failed cementless total hip arthroplasty with and without femoral osteolysis. Clin Orthop Relat Res:304–312Google Scholar
  24. 24.
    Stea S, Visentin M, Granchi D et al (2000) Cytokines and osteolysis around total hip prostheses. Cytokine 12:1575–1579PubMedGoogle Scholar
  25. 25.
    Goodman SB, Huie P, Song Y et al. (1998) Cellular profile and cytokine production at prosthetic interfaces. Study of tissues retrieved from revised hip and knee replacements. J Bone Jt Surg Br 80:531–539Google Scholar
  26. 26.
    Sabokbar A, Rushton N (1995) Role of inflammatory mediators and adhesion molecules in the pathogenesis of aseptic loosening in total hip arthroplasties. J Arthroplasty 10:810–816PubMedGoogle Scholar
  27. 27.
    Fiorito S, Magrini L, Goalard C (2003) Pro-inflammatory and anti-inflammatory circulating cytokines and periprosthetic osteolysis. J Bone Jt Surg Br 85:1202–1206Google Scholar
  28. 28.
    Granchi D, Verri E, Ciapetti G et al (1998) Bone-resorbing cytokines in serum of patients with aseptic loosening of hip prostheses. J Bone Jt Surg Br 80:912–917Google Scholar
  29. 29.
    Hernigou P, Intrator L, Bahrami T et al (1999) Interleukin-6 in the blood of patients with total hip arthroplasty without loosening. Clin Orthop Relat Res:147–154Google Scholar
  30. 30.
    Nakashima Y, Sun DH, Maloney WJ et al (1998) Induction of matrix metalloproteinase expression in human macrophages by orthopaedic particulate debris in vitro. J Bone Jt Surg Br 80:694–700Google Scholar
  31. 31.
    Kido A, Pap G, Nagler DK et al (2004) Protease expression in interface tissues around loose arthroplasties. Clin Orthop Relat Res:230–236Google Scholar
  32. 32.
    Takei I, Takagi M, Santavirta S et al (2000) Messenger ribonucleic acid expression of 16 matrix metalloproteinases in bone–implant interface tissues of loose artificial hip joints. J Biomed Mater Res 52:613–620PubMedGoogle Scholar
  33. 33.
    Sethi RK, Neavyn MJ, Rubash HE et al (2003) Macrophage response to cross-linked and conventional UHMWPE. Biomaterials 24:2561–2573PubMedGoogle Scholar
  34. 34.
    Haynes DR, Boyle SJ, Rogers SD et al (1998) Variation in cytokines induced by particles from different prosthetic materials. Clin Orthop Relat Res:223–230Google Scholar
  35. 35.
    Green TR, Fisher J, Stone M et al (1998) Polyethylene particles of a ‘critical size’ are necessary for the induction of cytokines by macrophages in vitro. Biomaterials 19:2297–2302PubMedGoogle Scholar
  36. 36.
    Yang SY, Ren W, Park Y et al (2002) Diverse cellular and apoptotic responses to variant shapes of UHMWPE particles in a murine model of inflammation. Biomaterials 23:3535–3543PubMedGoogle Scholar
  37. 37.
    Shanbhag AS, Jacobs JJ, Black J et al (1994) Macrophage/particle interactions: effect of size, composition and surface area. J Biomed Mater Res 28:81–90PubMedGoogle Scholar
  38. 38.
    Brooks RA, Wimhurst JA, Rushton N (2002) Endotoxin contamination of particles produces misleading inflammatory cytokine responses from macrophages in vitro. J Bone Jt Surg Br 84:295–299Google Scholar
  39. 39.
    Bi Y, Van De Motter RR, Ragab AA et al (2001) Titanium particles stimulate bone resorption by inducing differentiation of murine osteoclasts. J Bone Jt Surg Am 83-A:501–508Google Scholar
  40. 40.
    Skoglund B, Aspenberg P (2003) PMMA particles and pressure—a study of the osteolytic properties of two agents proposed to cause prosthetic loosening. J Orthop Res 21:196–201PubMedGoogle Scholar
  41. 41.
    McEvoy A, Jeyam M, Ferrier G et al (2002) Synergistic effect of particles and cyclic pressure on cytokine production in human monocyte/macrophages: proposed role in periprosthetic osteolysis. Bone 30:171–177PubMedGoogle Scholar
  42. 42.
    Fujishiro T, Nishikawa T, Shibanuma N et al (2004) Effect of cyclic mechanical stretch and titanium particles on prostaglandin E2 production by human macrophages in vitro. J Biomed Mater Res A 68:531–536PubMedGoogle Scholar
  43. 43.
    Goodman SB, Fornasier VL, Lee J et al (1990) The histological effects of the implantation of different sizes of polyethylene particles in the rabbit tibia. J Biomed Mater Res 24:517–524PubMedGoogle Scholar
  44. 44.
    Goodman SB, Chin RC, Magee FP (1992) Prostaglandin E2 production by the membrane surrounding loose and fixated cemented tibial hemiarthroplasties in the rabbit knee. Clin Orthop Relat Res:283–287Google Scholar
  45. 45.
    Spector M, Shortkroff S, Hsu HP et al (1990) Tissue changes around loose prostheses. A canine model to investigate the effects of an antiinflammatory agent. Clin Orthop Relat Res:140–152Google Scholar
  46. 46.
    Gelb H, Schumacher HR, Cuckler J et al (1994) In vivo inflammatory response to polymethylmethacrylate particulate debris: effect of size, morphology, and surface area. J Orthop Res 12:83–92PubMedGoogle Scholar
  47. 47.
    Nagase M, Udagawa E, Schumacher HR et al (1990) Prolonged inflammatory reactions induced by ceramic powders in the rat air pouch model. Nippon Seikeigeka Gakkai Zasshi 64:602–611PubMedGoogle Scholar
  48. 48.
    Yang S, Wu B, Mayton L et al (2002) IL-1Ra and vIL-10 gene transfer using retroviral vectors ameliorates particle-associated inflammation in the murine air pouch model. Inflamm Res 51:342–350PubMedGoogle Scholar
  49. 49.
    Schwarz EM, Lu AP, Goater JJ et al (2000) Tumor necrosis factor-alpha/nuclear transcription factor-kappaB signaling in periprosthetic osteolysis. J Orthop Res 18:472–480PubMedGoogle Scholar
  50. 50.
    Childs LM, Goater JJ, O'Keefe RJ et al (2001) Efficacy of etanercept for wear debris-induced osteolysis. J Bone Miner Res 16:338–347PubMedGoogle Scholar
  51. 51.
    Carmody EE, Schwarz EM, Puzas JE et al (2002) Viral interleukin-10 gene inhibition of inflammation, osteoclastogenesis, and bone resorption in response to titanium particles. Arthritis Rheum 46:1298–1308PubMedGoogle Scholar
  52. 52.
    Zhang X, Morham SG, Langenbach R et al (2001) Evidence for a direct role of cyclo-oxygenase 2 in implant wear debris-induced osteolysis. J Bone Miner Res 16:660–670PubMedGoogle Scholar
  53. 53.
    Epstein NJ, Warme BA, Spanogle J et al (2005) Interleukin-1 modulates periprosthetic tissue formation in an intramedullary model of particle-induced inflammation. J Orthop Res 23:501–510PubMedGoogle Scholar
  54. 54.
    Hsu H, Lacey DL, Dunstan CR et al (1999) Tumor necrosis factor receptor family member RANK mediates osteoclast differentiation and activation induced by osteoprotegerin ligand. Proc Natl Acad Sci USA 96:3540–3545PubMedGoogle Scholar
  55. 55.
    Nicholson GC, Malakellis M, Collier FM et al (2000) Induction of osteoclasts from CD14-positive human peripheral blood mononuclear cells by receptor activator of nuclear factor kappaB ligand (RANKL). Clin Sci (Lond) 99:133–140CrossRefGoogle Scholar
  56. 56.
    Quinn JM, Elliott J, Gillespie MT et al (1998) A combination of osteoclast differentiation factor and macrophage-colony stimulating factor is sufficient for both human and mouse osteoclast formation in vitro. Endocrinology 139:4424–4427PubMedGoogle Scholar
  57. 57.
    Simonet WS, Lacey DL, Dunstan CR et al (1997) Osteoprotegerin: a novel secreted protein involved in the regulation of bone density. Cell 89:309–319PubMedGoogle Scholar
  58. 58.
    Hofbauer LC, Schoppet M (2004) Clinical implications of the osteoprotegerin/RANKL/RANK system for bone and vascular diseases. JAMA 292:490–495PubMedGoogle Scholar
  59. 59.
    Ulrich-Vinther M, Carmody EE, Goater JJ et al (2002) Recombinant adeno-associated virus-mediated osteoprotegerin gene therapy inhibits wear debris-induced osteolysis. J Bone Jt Surg Am 84-A:1405–1412Google Scholar
  60. 60.
    Goater JJ, O'Keefe RJ, Rosier RN et al (2002) Efficacy of ex vivo OPG gene therapy in preventing wear debris induced osteolysis. J Orthop Res 20:169–173PubMedGoogle Scholar
  61. 61.
    Childs LM, Paschalis EP, Xing L et al (2002) In vivo RANK signaling blockade using the receptor activator of NF-kappaB:Fc effectively prevents and ameliorates wear debris-induced osteolysis via osteoclast depletion without inhibiting osteogenesis. J Bone Miner Res 17:192–199PubMedGoogle Scholar
  62. 62.
    Masui T, Sakano S, Hasegawa Y et al (2005) Expression of inflammatory cytokines, RANKL and OPG induced by titanium, cobalt–chromium and polyethylene particles. Biomaterials 26:1695–1702PubMedGoogle Scholar
  63. 63.
    Mandelin J, Li TF, Liljestrom M et al (2003) Imbalance of RANKL/RANK/OPG system in interface tissue in loosening of total hip replacement. J Bone Jt Surg Br 85:1196–1201Google Scholar
  64. 64.
    Gehrke T, Sers C, Morawietz L et al. (2003) Receptor activator of nuclear factor kappaB ligand is expressed in resident and inflammatory cells in aseptic and septic prosthesis loosening. Scand J Rheumatol 32:287–294PubMedGoogle Scholar
  65. 65.
    Haynes DR, Crotti TN, Potter AE et al (2001) The osteoclastogenic molecules RANKL and RANK are associated with periprosthetic osteolysis. J Bone Jt Surg Br 83:902–911Google Scholar
  66. 66.
    Horiki M, Nakase T, Myoui A et al (2004) Localization of RANKL in osteolytic tissue around a loosened joint prosthesis. J Bone Miner Metab 22:346–351PubMedGoogle Scholar
  67. 67.
    Takayanagi H, Ogasawara K, Hida S et al (2000) T-cell-mediated regulation of osteoclastogenesis by signalling cross-talk between RANKL and IFN-gamma. Nature 408:600–605PubMedGoogle Scholar
  68. 68.
    Rakshit DS, Ly K, Sengupta TK et al (2006) Wear debris inhibition of anti-osteoclastogenic signaling By IL6 and IFN-gamma: mechanistic insights and implications for periprosthetic osteolysis. J Bone Jt Surg Am 88:788-799Google Scholar
  69. 69.
    Sabokbar A, Fujikawa Y, Neale S et al (1997) Human arthroplasty derived macrophages differentiate into osteoclastic bone resorbing cells. Ann Rheum Dis 56:414–420PubMedCrossRefGoogle Scholar
  70. 70.
    Nakashima Y, Sun DH, Trindade MC et al (1999) Induction of macrophage C–C chemokine expression by titanium alloy and bone cement particles. J Bone Jt Surg Br 81:155–162Google Scholar
  71. 71.
    Haynes DR, Crotti TN, Zreiqat H (2004) Regulation of osteoclast activity in peri-implant tissues. Biomaterials 25:4877–4885PubMedGoogle Scholar
  72. 72.
    Yu X, Huang Y, Collin-Osdoby P et al (2004) CCR1 chemokines promote the chemotactic recruitment, RANKL development, and motility of osteoclasts and are induced by inflammatory cytokines in osteoblasts. J Bone Miner Res 19:2065–2077PubMedGoogle Scholar
  73. 73.
    Ishiguro N, Kojima T, Ito T et al (1997) Macrophage activation and migration in interface tissue around loosening total hip arthroplasty components. J Biomed Mater Res 35:399–406PubMedGoogle Scholar
  74. 74.
    Lassus J, Waris V, Xu JW et al (2000) Increased interleukin-8 (IL-8) expression is related to aseptic loosening of total hip replacement. Arch Orthop Trauma Surg 120:328–332PubMedGoogle Scholar
  75. 75.
    Shanbhag AS, Jacobs JJ, Black J et al (1995) Cellular mediators secreted by interfacial membranes obtained at revision total hip arthroplasty. J Arthroplasty 10:498–506PubMedCrossRefGoogle Scholar
  76. 76.
    Vermes C, Chandrasekaran R, Jacobs JJ et al (2001) The effects of particulate wear debris, cytokines, and growth factors on the functions of MG-63 osteoblasts. J Bone Jt Surg Am 83-A:201–211Google Scholar
  77. 77.
    Yao J, Cs-Szabo G, Jacobs JJ et al (1997) Suppression of osteoblast function by titanium particles. J Bone Jt Surg Am 79:107–112Google Scholar
  78. 78.
    Vermes C, Roebuck KA, Chandrasekaran R et al (2000) Particulate wear debris activates protein tyrosine kinases and nuclear factor kappaB, which down-regulates type I collagen synthesis in human osteoblasts. J Bone Miner Res 15:1756–1765PubMedGoogle Scholar
  79. 79.
    Pioletti DP, Leoni L, Genini D et al (2002) Gene expression analysis of osteoblastic cells contacted by orthopedic implant particles. J Biomed Mater Res 61:408–420PubMedGoogle Scholar
  80. 80.
    Zambonin G, Colucci S, Cantatore F et al (1998) Response of human osteoblasts to polymethylmetacrylate in vitro. Calcif Tissue Int 62:362–365PubMedGoogle Scholar
  81. 81.
    Wang ML, Nesti LJ, Tuli R et al (2002) Titanium particles suppress expression of osteoblastic phenotype in human mesenchymal stem cells. J Orthop Res 20:1175–1184PubMedGoogle Scholar
  82. 82.
    Wang ML, Tuli R, Manner PA et al (2003) Direct and indirect induction of apoptosis in human mesenchymal stem cells in response to titanium particles. J Orthop Res 21:697–707PubMedGoogle Scholar
  83. 83.
    Pioletti DP, Kottelat A (2004) The influence of wear particles in the expression of osteoclastogenesis factors by osteoblasts. Biomaterials 25:5803–5808PubMedGoogle Scholar
  84. 84.
    Quinn JM, Horwood NJ, Elliott J et al (2000) Fibroblastic stromal cells express receptor activator of NF-kappa B ligand and support osteoclast differentiation. J Bone Miner Res 15:1459–1466PubMedGoogle Scholar
  85. 85.
    Wei X, Zhang X, Zuscik MJ et al (2005) Fibroblasts express RANKL and support osteoclastogenesis in a COX-2-dependent manner after stimulation with titanium particles. J Bone Miner Res 20:1136–1148PubMedGoogle Scholar
  86. 86.
    Sabokbar A, Itonaga I, Sun SG et al (2005) Arthroplasty membrane-derived fibroblasts directly induce osteoclast formation and osteolysis in aseptic loosening. J Orthop Res 23:511–519PubMedGoogle Scholar
  87. 87.
    Yao J, Glant TT, Lark MW et al (1995) The potential role of fibroblasts in periprosthetic osteolysis: fibroblast response to titanium particles. J Bone Miner Res 10:1417–1427PubMedCrossRefGoogle Scholar
  88. 88.
    Manlapaz M, Maloney WJ, Smith RL (1996) In vitro activation of human fibroblasts by retrieved titanium alloy wear debris. J Orthop Res 14:465–472PubMedGoogle Scholar
  89. 89.
    Yaszay B, Trindade MC, Lind M et al (2001) Fibroblast expression of C–C chemokines in response to orthopaedic biomaterial particle challenge in vitro. J Orthop Res 19:970–976PubMedGoogle Scholar
  90. 90.
    Kotake S, Udagawa N, Hakoda M et al (2001) Activated human T cells directly induce osteoclastogenesis from human monocytes: possible role of T cells in bone destruction in rheumatoid arthritis patients. Arthritis Rheum 44:1003–1012PubMedGoogle Scholar
  91. 91.
    Gravallese EM, Manning C, Tsay A et al (2000) Synovial tissue in rheumatoid arthritis is a source of osteoclast differentiation factor. Arthritis Rheum 43:250–258PubMedGoogle Scholar
  92. 92.
    Kong YY, Feige U, Sarosi I et al (1999) Activated T cells regulate bone loss and joint destruction in adjuvant arthritis through osteoprotegerin ligand. Nature 402:304–309PubMedGoogle Scholar
  93. 93.
    Farber A, Chin R, Song Y et al (2001) Chronic antigen-specific immune-system activation may potentially be involved in the loosening of cemented acetabular components. J Biomed Mater Res 55:433–441PubMedGoogle Scholar
  94. 94.
    Arora A, Song Y, Chun L et al (2003) The role of the TH1 and TH2 immune responses in loosening and osteolysis of cemented total hip replacements. J Biomed Mater Res A 64:693–697PubMedGoogle Scholar
  95. 95.
    Baldwin L, Flanagan BF, McLaughlin PJ et al (2002) A study of tissue interface membranes from revision accord knee arthroplasty: the role of T lymphocytes. Biomaterials 23:3007–3014PubMedGoogle Scholar
  96. 96.
    Li TF, Santavirta S, Waris V et al (2001) No lymphokines in T-cells around loosened hip prostheses. Acta Orthop Scand 72:241–247PubMedGoogle Scholar
  97. 97.
    Jiranek W, Jasty M, Wang JT et al (1995) Tissue response to particulate polymethylmethacrylate in mice with various immune deficiencies. J Bone Jt Surg Am 77:1650–1661Google Scholar
  98. 98.
    Goodman S, Wang JS, Regula D et al (1994) T-lymphocytes are not necessary for particulate polyethylene-induced macrophage recruitment. Histologic studies of the rat tibia. Acta Orthop Scand 65:157–160PubMedCrossRefGoogle Scholar
  99. 99.
    Taki N, Tatro JM, Nalepka JL et al (2005) Polyethylene and titanium particles induce osteolysis by similar, lymphocyte-independent, mechanisms. J Orthop Res 23:376–383PubMedGoogle Scholar
  100. 100.
    Sandhu J, Waddell JE, Henry M et al. (1998) The role of T cells in polyethylene particulate induced inflammation. J Rheumatol 25:1794–1799PubMedGoogle Scholar
  101. 101.
    Childs LM, Goater JJ, O'Keefe RJ et al (2001) Effect of anti-tumor necrosis factor-alpha gene therapy on wear debris-induced osteolysis. J Bone Jt Surg Am 83-A:1789–1797Google Scholar
  102. 102.
    Hallab NJ, Anderson S, Stafford T et al (2005) Lymphocyte responses in patients with total hip arthroplasty. J Orthop Res 23:384–391PubMedGoogle Scholar
  103. 103.
    Davies AP, Willert HG, Campbell PA et al (2005) An unusual lymphocytic perivascular infiltration in tissues around contemporary metal-on-metal joint replacements. J Bone Jt Surg Am 87:18–27Google Scholar
  104. 104.
    DeHeer DH, Engels JA, DeVries AS et al (2001) In situ complement activation by polyethylene wear debris. J Biomed Mater Res 54:12–19PubMedGoogle Scholar
  105. 105.
    Santavirta S, Hoikka V, Eskola A et al (1990) Aggressive granulomatous lesions in cementless total hip arthroplasty. J Bone Jt Surg Br 72:980–984Google Scholar
  106. 106.
    Palecanda A, Paulauskis J, Al-Mutairi E et al (1999) Role of the scavenger receptor MARCO in alveolar macrophage binding of unopsonized environmental particles. J Exp Med 189:1497–1506PubMedGoogle Scholar
  107. 107.
    Palmbos PL, Sytsma MJ, DeHeer DH et al (2002) Macrophage exposure to particulate titanium induces phosphorylation of the protein tyrosine kinase lyn and the phospholipases Cgamma-1 and Cgamma-2. J Orthop Res 20:483–489PubMedGoogle Scholar
  108. 108.
    Maloney WJ, Sun DH, Nakashima Y et al (1998) Effects of serum protein opsonization on cytokine release by titanium–alloy particles. J Biomed Mater Res 41:371–376PubMedGoogle Scholar
  109. 109.
    Sun DH, Trindade MC, Nakashima Y et al (2003) Human serum opsonization of orthopedic biomaterial particles: protein-binding and monocyte/macrophage activation in vitro. J Biomed Mater Res A 65:290–298PubMedGoogle Scholar
  110. 110.
    Rezzonico R, Chicheportiche R, Imbert V et al (2000) Engagement of CD11b and CD11c beta2 integrin by antibodies or soluble CD23 induces IL-1beta production on primary human monocytes through mitogen-activated protein kinase-dependent pathways. Blood 95:3868–3877PubMedGoogle Scholar
  111. 111.
    Rezzonico R, Imbert V, Chicheportiche R et al (2001) Ligation of CD11b and CD11c beta(2) integrins by antibodies or soluble CD23 induces macrophage inflammatory protein 1 alpha (MIP-1 alpha) and MIP-1 beta production in primary human monocytes through a pathway dependent on nuclear factor-kappaB. Blood 97:2932–2940PubMedGoogle Scholar
  112. 112.
    Abbas S, Clohisy JC, Abu-Amer Y (2003) Mitogen-activated protein (MAP) kinases mediate PMMA-induction of osteoclasts. J Orthop Res 21:1041–1048PubMedGoogle Scholar
  113. 113.
    Boyle WJ, Simonet WS, Lacey DL (2003) Osteoclast differentiation and activation. Nature 423:337–342PubMedGoogle Scholar
  114. 114.
    Iotsova V, Caamano J, Loy J et al (1997) Osteopetrosis in mice lacking NF-kappaB1 and NF-kappaB2. Nat Med 3:1285–1289PubMedGoogle Scholar
  115. 115.
    Franzoso G, Carlson L, Xing L et al (1997) Requirement for NF-kappaB in osteoclast and B-cell development. Genes Dev 11:3482–3496PubMedGoogle Scholar
  116. 116.
    Clohisy JC, Hirayama T, Frazier E et al (2004) NF-kB signaling blockade abolishes implant particle-induced osteoclastogenesis. J Orthop Res 22:13–20PubMedGoogle Scholar
  117. 117.
    Ren W, Li XH, Chen BD et al (2004) Erythromycin inhibits wear debris-induced osteoclastogenesis by modulation of murine macrophage NF-kappaB activity. J Orthop Res 22:21–29PubMedGoogle Scholar
  118. 118.
    Miyanishi K, Trindade MC, Ma T et al (2003) Periprosthetic osteolysis: induction of vascular endothelial growth factor from human monocyte/macrophages by orthopaedic biomaterial particles. J Bone Miner Res 18:1573–1583PubMedGoogle Scholar
  119. 119.
    Shuai K, Liu B (2003) Regulation of JAK-STAT signalling in the immune system. Nat Rev Immunol 3:900–911PubMedGoogle Scholar
  120. 120.
    Sengupta TK, Talbot ES, Scherle PA et al (1998) Rapid inhibition of interleukin-6 signaling and Stat3 activation mediated by mitogen-activated protein kinases. Proc Natl Acad Sci USA 95:11107–11112PubMedGoogle Scholar
  121. 121.
    Ahmed ST, Ivashkiv LB (2000) Inhibition of IL-6 and IL-10 signaling and Stat activation by inflammatory and stress pathways. J Immunol 165:5227–5237PubMedGoogle Scholar
  122. 122.
    Kubo M, Hanada T, Yoshimura A (2003) Suppressors of cytokine signaling and immunity. Nat Immunol 4:1169–1176PubMedGoogle Scholar
  123. 123.
    Sochart DH (1999) Relationship of acetabular wear to osteolysis and loosening in total hip arthroplasty. Clin Orthop Relat Res:135–150Google Scholar
  124. 124.
    Ilchmann T, Markovic L, Joshi A et al (1998) Migration and wear of long-term successful Charnley total hip replacements. J Bone Jt Surg Br 80:377–381Google Scholar
  125. 125.
    Muratoglu OK, Bragdon CR, O'Connor DO et al (2001) A novel method of cross-linking ultra-high-molecular-weight polyethylene to improve wear, reduce oxidation, and retain mechanical properties. Recipient of the 1999 HAP Paul Award. J Arthroplasty 16:149–160PubMedGoogle Scholar
  126. 126.
    Muratoglu OK, Bragdon CR, O'Connor D et al (2001) Larger diameter femoral heads used in conjunction with a highly cross-linked ultra-high molecular weight polyethylene: a new concept. J Arthroplasty 16:24–30PubMedGoogle Scholar
  127. 127.
    Heisel C, Silva M, dela Rosa MA et al (2004) Short-term in vivo wear of cross-linked polyethylene. J Bone Jt Surg Am 86-A:748–751Google Scholar
  128. 128.
    Digas G, Karrholm J, Thanner J et al (2003) Highly cross-linked polyethylene in cemented THA: randomized study of 61 hips. Clin Orthop Relat Res:126–138Google Scholar
  129. 129.
    D'Antonio JA, Manley MT, Capello WN et al (2005) Five-year experience with Crossfire highly cross-linked polyethylene. Clin Orthop Relat Res 441:143–150PubMedGoogle Scholar
  130. 130.
    Engh CA, Sychterz CJ, Engh CA Jr (2005) Conventional ultra-high molecular weight polyethylene: a gold standard of sorts. Instr Course Lect 54:183–187PubMedGoogle Scholar
  131. 131.
    Barrack RL, Burak C, Skinner HB (2004) Concerns about ceramics in THA. Clin Orthop Relat Res:73–79Google Scholar
  132. 132.
    Capello WN, Dantonio JA, Feinberg JR et al (2005) Alternative bearing surfaces: alumina ceramic bearings for total hip arthroplasty. Instr Course Lect 54:171–176PubMedGoogle Scholar
  133. 133.
    Jazrawi LM, Kummer FJ, DiCesare PE (1998) Alternative bearing surfaces for total joint arthroplasty. J Am Acad Orthop Surg 6:198–203PubMedGoogle Scholar
  134. 134.
    Bourne RB, Barrack R, Rorabeck CH et al (2005) Arthroplasty options for the young patient: Oxinium on cross-linked polyethylene. Clin Orthop Relat Res 441:159–167PubMedGoogle Scholar
  135. 135.
    MacDonald SJ (2004) Metal-on-metal total hip arthroplasty: the concerns. Clin Orthop Relat Res:86–93Google Scholar
  136. 136.
    Cuckler JM (2005) The rationale for metal-on-metal total hip arthroplasty. Clin Orthop Relat Res 441:132–136PubMedGoogle Scholar
  137. 137.
    Pollice PF, Rosier RN, Looney RJ et al (2001) Oral pentoxifylline inhibits release of tumor necrosis factor-alpha from human peripheral blood monocytes: a potential treatment for aseptic loosening of total joint components. J Bone Jt Surg Am 83-A:1057–1061Google Scholar
  138. 138.
    Schwarz EM, Campbell D, Totterman S et al (2003) Use of volumetric computerized tomography as a primary outcome measure to evaluate drug efficacy in the prevention of peri-prosthetic osteolysis: a 1-year clinical pilot of etanercept vs. placebo. J Orthop Res 21:1049–1055PubMedGoogle Scholar
  139. 139.
    von Knoch M, Wedemeyer C, Pingsmann A et al (2005) The decrease of particle-induced osteolysis after a single dose of bisphosphonate. Biomaterials 26:1803–1808Google Scholar
  140. 140.
    von Knoch F, Heckelei A, Wedemeyer C et al (2005) The effect of simvastatin on polyethylene particle-induced osteolysis. Biomaterials 26:3549–3555Google Scholar
  141. 141.
    Bekker PJ, Holloway DL, Rasmussen AS et al (2005) A single-dose placebo-controlled study of AMG 162, a fully human monoclonal antibody to RANKL, in postmenopausal women. 2004. J Bone Miner Res 20:2275–2282PubMedGoogle Scholar
  142. 142.
    Takahashi N, Ozawa H (2005) A new treatment for osteoporosis using fully human monoclonal antibody to RANKL, AMG 162. Clin Calcium 15:43–48PubMedGoogle Scholar
  143. 143.
    Zwerina J, Hayer S, Tohidast-Akrad M et al (2004) Single and combined inhibition of tumor necrosis factor, interleukin-1, and RANKL pathways in tumor necrosis factor-induced arthritis: effects on synovial inflammation, bone erosion, and cartilage destruction. Arthritis Rheum 50:277–290PubMedGoogle Scholar
  144. 144.
    Dai S, Hirayama T, Abbas S et al (2004) The IkappaB kinase (IKK) inhibitor, NEMO-binding domain peptide, blocks osteoclastogenesis and bone erosion in inflammatory arthritis. J Biol Chem 279:37219–37222PubMedGoogle Scholar
  145. 145.
    Bossard MJ, Tomaszek TA, Levy MA et al (1999) Mechanism of inhibition of cathepsin K by potent, selective 1,5-diacylcarbohydrazides: a new class of mechanism-based inhibitors of thiol proteases. Biochemistry 38:15893–15902PubMedGoogle Scholar
  146. 146.
    Lark MW, Stroup GB, James IE et al (2002) A potent small molecule, nonpeptide inhibitor of cathepsin K (SB 331750) prevents bone matrix resorption in the ovariectomized rat. Bone 30:746–753PubMedGoogle Scholar
  147. 147.
    Visentin L, Dodds RA, Valente M et al (2000) A selective inhibitor of the osteoclastic V-H(+)-ATPase prevents bone loss in both thyroparathyroidectomized and ovariectomized rats. J Clin Invest 106:309–318PubMedCrossRefGoogle Scholar
  148. 148.
    Lark MW, Stroup GB, Dodds RA et al (2001) Antagonism of the osteoclast vitronectin receptor with an orally active nonpeptide inhibitor prevents cancellous bone loss in the ovariectomized rat. J Bone Miner Res 16:319–327PubMedGoogle Scholar
  149. 149.
    Shakespeare WC, Metcalf CA, 3rd, Wang Y et al (2003) Novel bone-targeted Src tyrosine kinase inhibitor drug discovery. Curr Opin Drug Discov Dev 6:729–741Google Scholar
  150. 150.
    Potter HG, Nestor BJ, Sofka CM et al (2004) Magnetic resonance imaging after total hip arthroplasty: evaluation of periprosthetic soft tissue. J Bone Jt Surg Am 86-A:1947–1954Google Scholar
  151. 151.
    Looney RJ, Boyd A, Totterman S et al (2002) Volumetric computerized tomography as a measurement of periprosthetic acetabular osteolysis and its correlation with wear. Arthritis Res 4:59–63PubMedGoogle Scholar
  152. 152.
    Puri L, Wixson RL, Stern SH et al (2002) Use of helical computed tomography for the assessment of acetabular osteolysis after total hip arthroplasty. J Bone Jt Surg Am 84-A:609–614Google Scholar

Copyright information

© Hospital for Special Surgery 2006

Authors and Affiliations

  • P. Edward Purdue
    • 1
  • Panagiotis Koulouvaris
    • 1
  • Bryan J. Nestor
    • 1
  • Thomas P. Sculco
    • 1
  1. 1.Osteolysis Research LaboratoryHospital for Special SurgeryNew YorkUSA

Personalised recommendations